The Victoza approval comes after a priority review by the FDA, and shortly after Novo Nordisk reported the results of the phase 3 ELLIPSE trial which showed the drug was able to reduce haemoglobin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback